JE
Jens Eric Regelin
About Jens Eric Regelin
Data last updated:
Jens Eric Regelin is a Director at Ferring Therapeutics Private Limited (since 2020) and Director at Ferring Laboratories Private Limited (since 2020). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹114 Cr; the largest is Ferring Therapeutics Private Limited at ₹109 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ferring Therapeutics Private Limited U74120MH2011PTC224424 | Director | 13 Oct 2020 | 2011 | ₹109 Cr (FY 2023) | Active |
 Ferring Laboratories Private Limited U74120TG2016PTC151173 | Director | 29 Oct 2020 | 2016 | ₹4.93 Cr (FY 2024) | Active |
Board colleagues of Jens Eric Regelin
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anindya Ghosh | 07663835 | Ferring Therapeutics Private Limited , Ferring Laboratories Private Limited | Managing Director |
| Piyali Pratibharanjan Das | Ferring Therapeutics Private Limited | Company Secretary | |
| Robert Flury | 09521393 | Ferring Therapeutics Private Limited | Director |
| Rohit Somani | Ferring Laboratories Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jens Eric Regelin
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jens Eric Regelin
Jens Eric Regelin currently holds 2 directorships: Ferring Therapeutics Private Limited (Director, since 13 Oct 2020, revenue ₹109 Cr (FY 2023)); Ferring Laboratories Private Limited (Director, since 29 Oct 2020, revenue ₹4.93 Cr (FY 2024)).
Jens Eric Regelin was first appointed on 13 Oct 2020 as Director at Ferring Therapeutics Private Limited.
The 2 current companies of Jens Eric Regelin that report revenue have a combined latest revenue of ₹114 Cr: Ferring Therapeutics Private Limited ₹109 Cr (FY 2023); Ferring Laboratories Private Limited ₹4.93 Cr (FY 2024).
The current boards of Jens Eric Regelin's companies include Anindya Ghosh (Ferring Therapeutics Private Limited), Piyali Pratibharanjan Das (Ferring Therapeutics Private Limited), Robert Flury (Ferring Therapeutics Private Limited), Rohit Somani (Ferring Laboratories Private Limited).